<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Wogonin is a <z:chebi fb="5" ids="47916">flavonoid</z:chebi> isolated from Scutellaria baicalensis Georgi, a traditional Chinese medicine, and it possesses <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and anti-inflammatory effects </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study is to investigate the in vivo effect of wogonin on <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e>/reperfusion injury in an open-chest anesthetized rat model, which was induced by 45-minute left coronary <z:mp ids='MP_0006134'>artery occlusion</z:mp> and 2-hour reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Rats were treated with wogonin (5, 10, and 20 mg/kg, intraperitoneal) 40 minutes before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> or treatment with 10 mg/kg of wogonin 15 minutes after occlusion </plain></SENT>
<SENT sid="3" pm="."><plain>Pretreatment with 10 mg/kg of wogonin significantly delayed the occurrence of <z:mp ids='MP_0009732'>ventricular premature contractions</z:mp> and <z:hpo ids='HP_0001649'>tachycardia</z:hpo>, and it suppressed the incidence of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo>, and mortality elicited by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> when compared with that in the control group, accompanied by reducing the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> scores </plain></SENT>
<SENT sid="4" pm="."><plain>After 2-hour reperfusion, pretreatment and posttreatment with wogonin significantly reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size and plasma levels of <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase muscle-brain fraction and <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase </plain></SENT>
<SENT sid="5" pm="."><plain>Wogonin also significantly reduced the elevation of plasma tissue <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α and <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> production in the myocardium with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>The expression of monocyte chemoattractant protein-1, phosphorylated p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase, p65 and IκBα, and active caspase-3 in ischemic myocardium pronouncedly increased in the control group; these were significantly attenuated by treatment with wogonin </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, wogonin demonstrated in vivo cardioprotective effects by the attenuation of the severity of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and irreversible <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury, which is associated with its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity and anti-inflammatory effects </plain></SENT>
<SENT sid="8" pm="."><plain>The suppression of nuclear factor-κB and p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase activation and the inhibition of monocyte chemoattractant protein-1 expression contribute to the beneficial effects of wogonin </plain></SENT>
</text></document>